Post-approval studies (Phase 4)Study completedNCT00055120
What this trial is testing
When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
Who this might be right for
HIV InfectionsAIDS-Related Opportunistic Infections
National Institute of Allergy and Infectious Diseases (NIAID) 283